Cargando…
Stem cell properties of peripheral blood endothelial progenitors are stimulated by soluble CD146 via miR-21: potential use in autologous cell therapy
Cell-based therapies constitute a real hope for the treatment of ischaemic diseases. One of the sources of endothelial progenitors for autologous cell therapy is Endothelial Colony Forming Cells (ECFC) that can be isolated from peripheral blood. However, their use is limited by their low number in t...
Autores principales: | Essaadi, Amel, Nollet, Marie, Moyon, Anaïs, Stalin, Jimmy, Simoncini, Stéphanie, Balasse, Laure, Bertaud, Alexandrine, Bachelier, Richard, Leroyer, Aurélie S., Sarlon, Gabrielle, Guillet, Benjamin, Dignat-George, Françoise, Bardin, Nathalie, Blot-Chabaud, Marcel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010456/ https://www.ncbi.nlm.nih.gov/pubmed/29925894 http://dx.doi.org/10.1038/s41598-018-27715-4 |
Ejemplares similares
-
A novel anti-CD146 antibody specifically targets cancer cells by internalizing the molecule
por: Nollet, Marie, et al.
Publicado: (2017) -
CD146/sCD146 in the Pathogenesis and Monitoring of Angiogenic and Inflammatory Diseases
por: Heim, Xavier, et al.
Publicado: (2020) -
Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastoma
por: Joshkon, Ahmad, et al.
Publicado: (2022) -
Role of CD146 (MCAM) in Physiological and Pathological Angiogenesis—Contribution of New Antibodies for Therapy
por: Joshkon, Ahmad, et al.
Publicado: (2020) -
Therapeutic and Diagnostic Antibodies to CD146: Thirty Years of Research on Its Potential for Detection and Treatment of Tumors
por: Stalin, Jimmy, et al.
Publicado: (2017)